⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Nancy L. Lewis, MD, MBS, FACP, sa stáva novou vedeckou riaditeľkou National Comprehensive Cancer Network (NCCN) USA - slovenčina Indonesia - Bahasa USA - Français USA - Deutsch APAC - Traditional Chinese USA - English USA - English Vietnam - Vietnamese
prnewswire.com
NVS
Dr Nancy L. Lewis mianowana dyrektorką naukową NCCN USA - Polski USA - español Indonesia - Bahasa Vietnam - Vietnamese USA - Français USA - Deutsch USA - slovenčina USA - Pусский APAC - Traditional Chinese Japan - Japanese Korea - 한국어 APAC - English USA -
prnewswire.com
NVS
Nancy L. Lewis, MD, MBS, FACP, nommée directrice scientifique du National Comprehensive Cancer Network (NCCN) USA - Français APAC - Traditional Chinese Indonesia - Bahasa USA - Deutsch USA - Polski Japan - Japanese Korea - 한국어 APAC - English USA - English
prnewswire.com
NVS
Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN) USA - English APAC - English Korea - 한국어 Japan - Japanese USA - Polski USA - slovenčina APAC - Traditional Chinese USA - čeština Indonesia -
prnewswire.com
NVS
Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN) USA - English USA - Polski Indonesia - Bahasa USA - Français USA - Deutsch Japan - Japanese APAC - English USA - slovenčina APAC -
prnewswire.com
NVS
Nancy L. Lewis, MD, MBS, FACP, nombrada directora científica de National Comprehensive Cancer Network USA - español USA - Polski USA - Pусский Indonesia - Bahasa Vietnam - Vietnamese USA - Français USA - Deutsch USA - slovenčina APAC - Traditional Chinese
prnewswire.com
NVS
Nancy L. Lewis, MD, MBS, FACP, wird neue wissenschaftliche Leiterin des National Comprehensive Cancer Network (NCCN) USA - Deutsch Korea - 한국어 USA - español USA - Polski Indonesia - Bahasa USA - Français Japan - Japanese Vietnam - Vietnamese USA - Pусский
prnewswire.com
NVS
$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics
globenewswire.com
PFE
NVS
SNY
AZN
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
globenewswire.com
NVS
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
globenewswire.com
NVS